Clinical trial
Clinical and Biochemical Assessment of the Course of Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis
NCT04474717 is registered in ClinicalTrials.gov with Ryazan State Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical and Biochemical Assessment of the Course of Chronic Obstructive Pulmonary Disease in Combination With Atherosclerosis
- Lead sponsor
- Ryazan State Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 15, 2020
- Completion date
- July 19, 2023
- Enrollment
- 476 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease, peripheral artery disease